In the following video, Fool contributor Maxxwell Chatsko talks with health care analyst Max Macaluso and recaps the latest earnings results from the pharmaceutical industry. These companies each saw healthy gains in operating results and have big upcoming launches, such as Invokana from Johnson & Johnson (JNJ 0.70%) and Eliquis from Pfizer (PFE 0.53%). Nonetheless, investors will need to keep a long-term focus when viewing these complex pharmaceutical giants.
